Manufacturing

Pharmaceutical Outsourcing Manufacturing

Contract development and manufacturing companies, or CDMOs, provide a wide range of drug development, formulation and manufacturing services to companies that need outsourcing help to bring pharmaceutical products to market.

Full-service contract development and manufacturing companies can take on every aspect of drug development and manufacturing – many can develop a variety of dosage forms. Specialized CDMOs typically concentrate on one kind of dosage form.

Services offered by contract manufacturing organizations typically include, but are not limited to:

  • Formulation
  • Analytical Services
  • Blending
  • Coating
  • Tableting
  • Parenteral Product R&D and Manufacturing
  • Aseptic Filling
  • Unit Dose Semi-Solids
  • Transdermal Product Development and Manufacturing
  • Topicals
  • Converting
  • Packaging
  • Serialization
  • Shipment

Filter

Hide Filter

  • An Interview With... Peter Soelkner, Managing Director, Vetter Pharma International GmbH

    Friday, March 17, 2017
    There has always been a variety of challenges affecting the parenteral manufacturing industry and its participants. read more

  • A View to Strategic Partnering

    Friday, March 17, 2017
    Any human enterprise is subject to challenge from its conceptual stage; from financial hurdles to technology and expertise, they all contribute to the success or failure of our goals. The typical business cycle dictates that we need to define our ... read more

  • Anticipating Future Guidelines By Utilizing The Latest Technologies In Particle Characterization

    Friday, March 17, 2017
    The presence of particulate matter in pharmaceutical products con-tinues to be one of the top reasons for recall. This year, 11 of the 54 safety alerts issued by the FDA were for the presence of particulates in drug and therapeutic biological ... read more

  • Achieving Security of Supply with Effective Particle Engineering

    Wednesday, March 15, 2017
    Targeted particle engineering for solid dosage drug formulations has become an imperative given the challenging compounds in the pharmaceutical pipeline, the growing interest in inhaled delivery, and the move to continuous manufacturing. Contract ... read more

  • Advancing Solid Dose Processing Efficiency and Effectiveness

    Wednesday, March 15, 2017
    Because oral solid dose (OSD) pharmaceuticals will remain the dominant dose form, the pharmaceutical industry will continue to be responsible for the high-quality manufacture of hundreds of millions of individual doses every day, every year ... read more

  • Industry Benchmark

    Wednesday, March 15, 2017
    At the heart of That’s Nice is the Nice Insight division, which provides data and analysis from proprietary annual surveys as well as custom primary and secondary research of many kinds. Nice Insight is tasked every year with conducting a series of ... read more

  • Nice Insight: 2017 Industry Leaders

    Wednesday, March 15, 2017
    Nice Insight conducted seven annual studies to survey the pharma landscape and measure what buyers in the market want. These surveys were deployed to respondents in the diverse and dynamic sectors of CDMO, CRO, Equipment, Intermediate, ... read more

  • Equipment Must Integrate

    Wednesday, March 15, 2017
    Modern pharmaceutical manufacturing equipment and associated analytical instrumentation is the fundamental ‘hardware’ required to produce safe, effective, highquality medicinal products. To meet the challenges from increasingly downward price ... read more

  • Spending on Excipients Grows & Diversifies

    Wednesday, March 15, 2017
    Pharmaceutical excipients are used in combination with APIs in multiple medicinal products, including tablets, capsules, oral liquids, transdermal patches, implants and inhalers. Traditionally, these excipients were used to add bulk to ... read more

  • Changes In the Wind for the CDMO Market

    Wednesday, March 15, 2017
    The global pharmaceutical market continues to grow at a healthy rate. According to research firm Evaluate Pharma, the global drug market will expand at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2022, with biologics accounting for ... read more

  • Innovation And Partnership Through Experience And Acquisition

    Wednesday, March 15, 2017
    The pharmaceutical marketplace is more global than ever and, as companies fight for market share in this increasingly competitive landscape, contract development and manufacturing organizations (CDMOs) are becoming more important than ever. read more

  • There Is Almost No Aspect of the Life Sciences and Related Industries That Big Data Cannot Impact.

    Wednesday, March 15, 2017
    It can help in disease pattern analysis by bringing information together in new ways; it facilitates drug discovery by enabling advanced search capabilities for analyzing millions of publications, patents and clinical trial documents; it can also ... read more

  • Next-Generation OSD Manufacturing Strategy

    Wednesday, March 15, 2017
    The Facility of the Future has to be more agile, flexible and efficient than it is today. How to get there? By innovating — introducing new processing concepts, analytics and control — and pulling it together with attention to flow and ergonomics... read more

  • Dissolving Boundaries In Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

    Wednesday, March 15, 2017
    Marken is a leading patient-centric supply chain logistics organization with a complete focus on the pharmaceutical and life-sciences industries. Its state-ofthe- art GMP-compliant network includes 10 GMP-compliant depots and 45 worldwide logistic ... read more

  • Designing a Better Single-use Facility

    Wednesday, March 15, 2017
    Although single-use, disposable technologies (SUTs) have been around for decades, continued development and implementation of this innovative process technology is needed to help accelerate the advancement of biopharmaceutical drug development. read more
Page